Substrates and Cyclic Peptide Inhibitors of the Oligonucleotide-Activated Sirtuin 7

  • Julie E. Bolding
  • , Alexander L. Nielsen
  • , Iben Jensen
  • , Tobias N. Hansen
  • , Line A. Ryberg
  • , Samuel T. Jameson
  • , Pernille Harris
  • , Günther H. J. Peters
  • , John M. Denu
  • , Joseph M. Rogers*
  • , Christian A. Olsen*
  • *Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

60 Downloads (Orbit)

Abstract

The sirtuins are NAD+-dependent lysine deacylases, comprising seven isoforms (SIRT1–7) in humans, which are involved in the regulation of a plethora of biological processes, including gene expression and metabolism. The sirtuins share a common hydrolytic mechanism but display preferences for different ϵ-N-acyllysine substrates. SIRT7 deacetylates targets in nuclei and nucleoli but remains one of the lesser studied of the seven isoforms, in part due to a lack of chemical tools to specifically probe SIRT7 activity. Here we expressed SIRT7 and, using small-angle X-ray scattering, reveal SIRT7 to be a monomeric enzyme with a low degree of globular flexibility in solution. We developed a fluorogenic assay for investigation of the substrate preferences of SIRT7 and to evaluate compounds that modulate its activity. We report several mechanism-based SIRT7 inhibitors as well as de novo cyclic peptide inhibitors selected from mRNA-display library screening that exhibit selectivity for SIRT7 over other sirtuin isoforms, stabilize SIRT7 in cells, and cause an increase in the acetylation of H3 K18.
Original languageEnglish
Article numbere20231459
JournalAngewandte Chemie International Edition
Volume62
Number of pages11
ISSN1433-7851
DOIs
Publication statusPublished - 2023

Fingerprint

Dive into the research topics of 'Substrates and Cyclic Peptide Inhibitors of the Oligonucleotide-Activated Sirtuin 7'. Together they form a unique fingerprint.

Cite this